The ATR-Chk1 signaling pathway mediates cellular responses to DNA damage and replication stress and is composed of a number of core factors that are conserved throughout eukaryotic organisms. However, humans and other higher eukaryotic species possess additional factors that are implicated in the regulation of this signaling network but that have not been extensively studied. Here we show that RHINO (for Rad9, Rad1, Hus1 interacting nuclear orphan) forms complexes with both the 9-1-1 checkpoint clamp and TopBP1 in human cells even in the absence of treatments with DNA damaging agents via direct interactions with the Rad9 and Rad1 subunits of the 9-1-1 checkpoint clamp and with the ATR kinase activator TopBP1. The interaction of RHINO with 9-1-1 was of sufficient affinity to allow for the purification of a stable heterotetrameric RHINO-Rad9-Hus1-Rad1 complex in vitro. In human cells, a portion of RHINO localizes to chromatin in the absence of DNA damage, and this association is enriched following UV irradiation. Furthermore, we find that the tethering of a Lac Repressor (LacR)-RHINO fusion protein to LacO repeats in chromatin of mammalian cells induces Chk1 phosphorylation in a Rad9- and Claspin-dependent manner. Lastly, the loss of RHINO partially abrogates ATR-Chk1 signaling following UV irradiation without impacting the interaction of the 9-1-1 clamp with TopBP1 or the loading of 9-1-1 onto chromatin. We conclude that RHINO is a bona fide regulator of ATR-Chk1 signaling in mammalian cells.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614876PMC
http://dx.doi.org/10.4161/15384101.2014.967076DOI Listing

Publication Analysis

Top Keywords

atr-chk1 signaling
16
9-1-1 checkpoint
12
checkpoint clamp
12
dna damage
8
rad9 rad1
8
clamp topbp1
8
human cells
8
mammalian cells
8
rhino
6
9-1-1
6

Similar Publications

Molecular mechanisms restoring olaparib efficacy through ATR/CHK1 pathway inhibition in olaparib-resistant BRCA1/2 ovarian cancer models.

Biochim Biophys Acta Mol Basis Dis

February 2025

Department of Medical Biophysics, Institute of Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, 141/143 Pomorska Street, 90-236 Lodz, Poland. Electronic address:

Article Synopsis
  • Olaparib resistance in ovarian cancer patients calls for new strategies, leading to the creation of a patient-derived xenograft model to study this issue.
  • In experiments, olaparib-resistant tumors were treated with olaparib alone, or combined with ATR and CHK1 inhibitors, revealing that these combinations effectively hindered tumor growth and altered key molecular signaling pathways.
  • The study enhances our understanding of how to combat olaparib resistance in high-grade serous ovarian cancer with BRCA1/2 mutations, suggesting that targeting the ATR/CHK1 pathways could improve treatment outcomes for patients who are initially unresponsive to olaparib.
View Article and Find Full Text PDF
Article Synopsis
  • Oncogenic mutations like those in KRAS cause transcription-replication conflicts (TRCs) in pancreatic ductal adenocarcinoma (PDAC), making them more common in these cancer cells than in other tumors or normal cells.
  • The study identifies base-excision repair (BER) factors as key regulators of TRCs, with BER inhibitors increasing TRCs by disrupting RNA polymerase II and R-loop dynamics.
  • Combining ATR and BER inhibitors shows promise in enhancing DNA damage and reducing PDAC cell growth, emphasizing the therapeutic potential of targeting these pathways in cancer treatment.
View Article and Find Full Text PDF

Cigarette smoke, a complex mixture produced by tobacco combustion, contains a variety of carcinogens and can trigger DNA damage. Overactivation of c-MET, a receptor tyrosine kinase, may cause cancer and cellular DNA damage, but the underlying mechanisms are unknown. In this work, we investigated the mechanisms of cigarette smoke extract (CSE) induced malignant transformation and DNA damage in human bronchial epithelial cells (BEAS-2B).

View Article and Find Full Text PDF

Oleandrin enhances radiotherapy sensitivity in lung cancer by inhibiting the ATM/ATR-mediated DNA damage response.

Phytother Res

August 2024

Translational Medicine Research Center, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Hangzhou First People's Hospital, Hangzhou, China.

Despite active clinical trials on the use of Oleandrin alone or in combination with other drugs for the treatment of solid tumors, the potential synergistic effect of Oleandrin with radiotherapy remains unknown. This study reveals a new mechanism by which Oleandrin targets ATM and ATR kinase-mediated radiosensitization in lung cancer. Various assays, including clonogenic, Comet, immunofluorescence staining, apoptosis and Cell cycle assays, were conducted to evaluate the impact of oleandrin on radiation-induced double-strand break repair and cell cycle distribution.

View Article and Find Full Text PDF

The DNA replication stress (DRS) response is a crucial homeostatic mechanism for maintaining genome integrity in the face of intrinsic and extrinsic barriers to DNA replication. Importantly, DRS is often significantly increased in tumor cells, making tumors dependent on the cellular DRS response for growth and survival. Rad9-Hus1-Rad1 Interacting Nuclear Orphan 1 (RHNO1), a protein involved in the DRS response, has recently emerged as a potential therapeutic target in cancer.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!